BofA/Merrill Lynch Upgrades Biogen (BIIB) to Buy

April 12, 2013 9:00 AM EDT
Get Alerts BIIB Hot Sheet
Price: $280.89 -3.44%

Rating Summary:
    17 Buy, 16 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 48 | New: 20
Trade BIIB Now!
Join SI Premium – FREE
BofA/Merrill Lynch upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $246.00 (from $187.00).

For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.

Shares of Biogen closed at $200.26 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment